Noll Campbell
- Associate Professor of Pharmacy Practice
Office and Contact
Education
PharmD - Butler University - Pharmacy - 2002
PharmD - Butler University - Pharmacy - 2002
Research Interests
adverse cognitive effects of medications in older adults, geriatric pharmacotherapy
adverse cognitive effects of medications in older adults, geriatric pharmacotherapy
Teaching Interests
geriatric pharmacotherapy, dementia
geriatric pharmacotherapy, dementia
Selected Grants
2024 - National Institutes of Health
2023 - National Institutes of Health (Co-I)
2022 - National Institutes of Health (Co-PI)
Selected Publications
Hill JR, Ganci A, Campbell NL, Pickett AC, Chui MA, Abebe E, Holden RJ. Developing mHealth IT for older adult medication safety: remote participatory co-design using the RAPID Method. JMIR Human Factors. JMIR Hum Factors 2026;13:e82366. doi: 10.2196/82366. PMID: 41773483.
Hill JR, Patel H, Gardner B, Ganci A, Campbell NL, Chui MA, Abebe E, Holden RJ. A digital health kiosk is acceptable, usable, and improves decisions about high-risk over-the-counter medications when used by older adults: Results of formative user testing. J Am Pharm Assoc (2003). 2025 Sep-Oct;65(5):102451. doi: 10.1016/j.japh.2025.102451. Epub 2025 Jun 11. PMID: 40513943; PMCID: PMC12291175.
Ahmed I, Zillich AJ, Campbell NL, Sowinski KM, Foster DR. Long-term opioid therapy in older adults: Incidence and risk factors related to patient characteristics and initial opioid dispensed. J Am Pharm Assoc (2003). 2025 Mar-Apr;65(2):102311. doi: 10.1016/j.japh.2024.102311. Epub 2024 Dec 10. PMID: 39667526.
American Geriatrics Society Beers Criteria® Alternatives Panel; Steinman MA. Alternative Treatments to Selected Medications in the 2023 American Geriatrics Society Beers Criteria®. J Am Geriatr Soc. 2025 Sep;73(9):2657-2677. doi: 10.1111/jgs.19500. Epub 2025 Jul 23. PMID: 40697073; PMCID: PMC12448428.
Jolliff A, Loganathar P, Holden RJ, Linden A, Patel H, Lee JR, Ganci A, Campbell N, Boustani M, Werner NE. Creating user personas to represent the needs of dementia caregivers who support medication management at home: persona development and qualitative study. JMIR Aging. 2025;8:e63944. doi:10.2196/63944.
Khalil H, Keshk N, Khan BA, Gao S, Khan SH, Campbell NL. Community-based Anticholinergic Exposure and Delirium: A Systematic Review. Delirium 2025; doi:10.56392/001c.141069.
Devlin JW, Sieber F, Akeju O, Khan BA, MacLullich AMJ, Marcantonio ER, Oh ES, Agar MR, Avelino-Silva TJ, Berger M, Burry L, Colantuoni EA, Evered LA, Girard TD, Han JH, Hosie A, Hughes C, Jones RN, Pandharipande PP, Subramanian B, Travison TG, van den Boogaard M, Inouye SK; Network for Investigation of Delirium: Unifying Scientists (NIDUS) Writing Group. Advancing Delirium Treatment Trials in Older Adults: Recommendations for Future Trials From the Network for Investigation of Delirium: Unifying Scientists (NIDUS). Crit Care Med. 2025 Jan 1;53(1):e15-e28. doi: 10.1097/CCM.0000000000006514. Epub 2024 Nov 22. PMID: 39774202.
Campbell NL, Holden RJ, Gao S, Unverzagt FW, Lane KA, Carter A, Harrington AB, Manoharan S, Manoharan N, Rosenthal DL, Pitts C, Pelkey K, Papineau E, Lauck D, Keshk N, Alamer K, Khalil H, Boustani MA. Deprescribing Anticholinergics to Preserve Brain Health: Reducing the Risk of Dementia through Deprescribing (R2D2): Study Protocol for a Randomized Clinical Trial. Trials. 2024 Nov 22;25(1):788. doi:10.1186/s13063-024-08618-4. PMID: 39578926.
Dubois B, Villain N, Schneider L, Fox N, Campbell N, Galasko D, Kivipelto M, Jessen F, Hanseeuw B, Boada M, Barkhof F, Nordberg A, Froelich L, Waldemar G, Frederiksen S, Padovani A, Planche V, Rowe C, Bejanin A, Ibanez A, Cappa S, Caramelli P, Nitrini R, Allegri R, Slachevsky A, Cruz de Souza L, Bozoki A, Widera E, Blennow K, Ritchie C, Agronin M, Lopera F, Delano-Wood L, Bombois S, Levy R, Thambisetty M, Georges J, Jones DT, Lavretsky H, Schott J, Gatchel J, Swantek S, Newhouse P, Feldman HF, Frisoni GB. Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation. JAMA Neurol. Published online November 01, 2024. doi:10.1001/jamaneurol.2024.3770
Montrose JA, Desai A, Nephew L, Patidar K, Ghabril M, Campbell NL, Chalasani N, Qiu Y, Hays M, Orman E. Medication burden and anticholinergic use are associated with overt hepatic encephalopathy in individuals with cirrhosis. Hepatol Commun. 2024 Jul 22;8(8):e0460. doi: 10.1097/HC9.0000000000000460. PMID: 39037388; PMCID: PMC11265776.